Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Walter

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Blood Advances|March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditionsAmy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Cell Reports|April 5, 2018
Systematic Analysis of Splice-Site-Creating Mutations in CancerReyka G Jayasinghe, Song Cao, Qingsong Gao, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Blood|January 14, 2017
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapyEric J Duncavage, Geoffrey L Uy, Allegra A Petti, et al.
Medrxiv : the Preprint Server for Health Sciences|January 30, 2023
Genomic landscape of <i>TP53</i> -mutated myeloid malignanciesHaley J Abel, Karolyn A Oetjen, Christopher A Miller, et al.
Plos Genetics|July 11, 2014
Clonal architecture of secondary acute myeloid leukemia defined by single-cell sequencingAndrew E O Hughes, Vincent Magrini, Ryan Demeter, et al.
Nature|December 10, 2014
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemiaTerrence N Wong, Giridharan Ramsingh, Andrew L Young, et al.
Blood Advances|March 22, 2023
Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditionsAmy E DeZern, Johannes B Goll, R Coleman Lindsley, et al.
Cell Reports|April 5, 2018
Systematic Analysis of Splice-Site-Creating Mutations in CancerReyka G Jayasinghe, Song Cao, Qingsong Gao, et al.
Nature Communications|February 2, 2018
Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potentialTerrence N Wong, Christopher A Miller, Matthew R M Jotte, et al.
Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Blood|February 14, 2008
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemiaMichael H Tomasson, Zhifu Xiang, Richard Walgren, et al.
The New England Journal of Medicine|November 1, 2018
Immune Escape of Relapsed AML Cells after Allogeneic TransplantationMatthew J Christopher, Allegra A Petti, Michael P Rettig, et al.
Pageof 11